GlassScriptPhysician profile
Robby L Keith
NPI 1497781082
$11,999.17
in general payments reported to CMS, 2019-2025
35 companies · $974 in 2025
The $974 reported for 2025 was more than what 77% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $718 · 2020: $569 · 2021: $862 · 2022: $951 · 2023: $5,622 · 2024: $2,304 · 2025: $974.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,940 · Education: $3,089 · Travel and Lodging: $1,871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,939.93 |
| Education | $3,088.99 |
| Travel and Lodging | $1,870.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,274.98 | 2023-2024 | Ion, Da Vinci Surgical System |
| Pulmonx Corporation | $1,438.99 | 2022-2024 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Glaxosmithkline, LLC. | $1,365.50 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Regeneron Healthcare Solutions, INC. | $783.67 | 2019-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $773.65 | 2019-2024 | Uptravi, Opsumit |
| Genzyme Corporation | $722.73 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $470.26 | 2019-2025 | Ofev |
| Astrazeneca Pharmaceuticals LP | $396.89 | 2020-2025 | Fasenra, Breztri |
| Axsome Therapeutics, INC. | $161.34 | 2023-2025 | Sunosi |
| Grifols USA, LLC | $159.05 | 2020-2024 | Prolastin-C Liquid |
| Genentech USA, INC. | $142.88 | 2019-2024 | Xolair |
| United Therapeutics Corporation | $131.60 | 2022-2023 | Tyvaso |
| Electromed, INC. | $117.50 | 2019-2025 | Smartvest |
| Insmed, INC. | $102.10 | 2024-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $87.80 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $86.52 | 2023 | Lifevest |
| Jazz Pharmaceuticals INC. | $85.54 | 2020-2022 | |
| Amgen INC. | $81.79 | 2023-2025 | Tezspire |
| Verona Pharma, INC. | $68.81 | 2025 | Ohtuvayre |
| Sunovion Pharmaceuticals INC. | $67.17 | 2019-2020 | |
| Baxter Healthcare | $66.72 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Eisai INC. | $60.32 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $56.62 | 2019-2024 | Capvaxive |
| Harmony Biosciences LLC | $45.45 | 2024-2025 | |
| Pfizer INC. | $41.51 | 2023-2024 | |
| Viatris Specialty LLC | $33.80 | 2025 | Yupelri |
| Alexion Pharmaceuticals, INC. | $32.53 | 2019-2023 | Ultomiris |
| Vifor Pharma, INC. | $24.61 | 2025 | Zemaira |
| Mallinckrodt Enterprises LLC | $21.90 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $20.58 | 2022 | |
| Mallinckrodt Hospital Products INC. | $19.03 | 2024 | Terlivaz |
| Advanced Respiratory, INC | $17.47 | 2020 | |
| La Jolla Pharmaceutical Company | $13.77 | 2020 | |
| Abbvie INC. | $13.41 | 2023 | |
| Allergan, INC. | $12.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robby Keith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.